All partners will receive the highest recognition for their support to EBJIS.
More information will follow soon.
For further information or to make a booking, please contact the conference organiser at firstname.lastname@example.org
BONESUPPORT™ develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT®.
The company portfolio includes CERAMENT® BONE VOID FILLER, CERAMENT® G with gentamicin, and CERAMENT® V with vancomycin.
Today more than 55.000 patients have been treated with products from the CERAMENT platform. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver.
The company is based in Lund, Sweden. Please visit www.bonesupport.com for more information. BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.